Cargando…
Epitope Mapping of Conformational V2-specific Anti-HIV Human Monoclonal Antibodies Reveals an Immunodominant Site in V2
In the case-control study of the RV144 vaccine trial, the levels of antibodies to the V1V2 region of the gp120 envelope glycoprotein were found to correlate inversely with risk of HIV infection. This recent demonstration of the potential role of V1V2 as a vaccine target has catapulted this region in...
Autores principales: | Mayr, Luzia M., Cohen, Sandra, Spurrier, Brett, Kong, Xiang-Peng, Zolla-Pazner, Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3726596/ https://www.ncbi.nlm.nih.gov/pubmed/23923028 http://dx.doi.org/10.1371/journal.pone.0070859 |
Ejemplares similares
-
Crystal structure analysis of anti-V2 mAb 2158 suggests a conformational epitope involving an N-linked glycan
por: Spurrier, B, et al.
Publicado: (2012) -
Rationally Targeted Mutations at the V1V2 Domain of the HIV-1 Envelope to Augment Virus Neutralization by Anti-V1V2 Monoclonal Antibodies
por: Shen, Guomiao, et al.
Publicado: (2015) -
The immunodominant and neutralization linear epitopes for SARS-CoV-2
por: Lu, Shuai, et al.
Publicado: (2021) -
Mapping Immunodominant Antibody Epitopes of Abrin
por: Alcalay, Ron, et al.
Publicado: (2020) -
P20-09. Worldwide epitope prevalence of crystallographically resolved anti-V3 antibodies
por: Swetnam, J, et al.
Publicado: (2009)